Abstract
Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.
Original language | English (US) |
---|---|
Pages (from-to) | 147-157 |
Number of pages | 11 |
Journal | American journal of hematology |
Volume | 79 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2005 |
Keywords
- Hyperviscosity syndrome
- Lymphoplasmacytic lymphoma
- Monoclonal antibody therapy
- Monoclonal gammopathy
- Waldenström macroglobulinemia
ASJC Scopus subject areas
- Hematology